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The Rho Termination Factor of
Clostridium botulinum Contains a
Prion-Like Domain with a Highly
Amyloidogenic Core
Irantzu Pallarès*, Valentin Iglesias and Salvador Ventura*
Institut de Biotecnologia i Biomedicina and Departament de Bioquìmica i Biologia Molecular, Universitat Autònoma de
Barcelona, Barcelona, Spain
Prion-like proteins can switch between a soluble intrinsically disordered conformation
and a highly ordered amyloid assembly. This conformational promiscuity is encoded
in specific sequence regions, known as prion domains (PrDs). Prions are best known
as the causative factors of neurological diseases in mammals. However, bioinformatics
analyses reveal that proteins bearing PrDs are present in all kingdoms of life, including
bacteria, thus supporting the idea that they serve conserved beneficial cellular functions.
Despite the proportion of predicted prion-like proteins in bacterial proteomes is generally
low, pathogenic species seem to have a higher prionic load, suggesting that these
malleable proteins may favor pathogenic traits. In the present work, we performed
a stringent computational analysis of the Clostridium botulinum pathogen proteome
in the search for prion-like proteins. A total of 54 candidates were predicted for this
anaerobic bacterium, including the transcription termination Rho factor. This RNA-
binding protein has been shown to play a crucial role in bacterial adaptation to changing
environments. We show here that the predicted disordered PrD domain of this RNA-
binding protein contains an inner, highly polar, asparagine-rich short sequence able
to spontaneously self-assemble into amyloid-like structures, bearing thus the potential
to induce a Rho factor conformational switch that might rewire gene expression in
response to environmental conditions.
Keywords: prion, bacteria, Clostridium, protein aggregation, amyloid
INTRODUCTION
Amyloid forming proteins are found in all kingdoms of life, from Bacteria to Animalia (Fowler
et al., 2007; Eichner and Radford, 2011; Sanchez de Groot et al., 2012). Although amyloid formation
is associated with the onset of debilitating human disorders such as Alzheimer’s, or Parkinson’s
(Maries et al., 2003; Stohr et al., 2012), the amyloid fold is also exploited for evolutionary selected
biological functions by diverse species, including humans (Chiti and Dobson, 2006; Furukawa
and Nukina, 2013). Prions are a particular type of amyloids that can switch between soluble
and self-templating aggregated states. In the so-called functional prions, this property is used to
perform important functions, acting as epigenetic elements and supporting beneﬁcial roles in cell
physiology (Newby and Lindquist, 2013).
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The conformational duality of prion-like proteins resides
in structurally independent, low complexity, prion-forming
domains (PrDs), usually enriched in asparagine (N) and
glutamine (Q) residues (Dorsman et al., 2002; Fandrich and
Dobson, 2002; Halfmann et al., 2011). This composition endorses
the domains with intrinsic structural disorder, which enables self-
assembly without a requirement for conformational unfolding
(Fuxreiter, 2012; Malinovska et al., 2013). Much research has
gone in the recent years into uncovering how prion propensities
are encoded in protein sequences (Alberti et al., 2009; Toombs
et al., 2010; MacLea et al., 2015; Sabate et al., 2015a) and several
algorithms exploit this knowledge to identify new putative prion
proteins (Toombs et al., 2012; Espinosa Angarica et al., 2013,
2014; Lancaster et al., 2014; Sabate et al., 2015b; Zambrano
et al., 2015). The high-throughput analysis of proteomes using
these programs has led to the identiﬁcation of thousands of
new potential prion-like proteins in organisms belonging to all
taxonomic subdivisions (Espinosa Angarica et al., 2013). The
results show that, in general, the number of prions per genome
is low, less than 1% of the complete proteome (Michelitsch and
Weissman, 2000; Harrison andGerstein, 2003; Espinosa Angarica
et al., 2013). Ontology analysis indicates that PrD-containing
proteins are associated with a great variety of physiological
functions, supporting prion-like proteins acting as beneﬁcial
elements for organisms.
In a previous work, we have used our algorithm PrionScan to
analyze 839 diﬀerent bacteria proteomes, detecting 2200 putative
prions in these organisms (Espinosa Angarica et al., 2013,
2014). Interestingly, we found a special enrichment in proteins
containing PrDs in pathogenic bacteria (Espinosa Angarica et al.,
2013). A signiﬁcant number of these proteins are DNA or RNA
binding proteins (Iglesias et al., 2015), which might be involved
in host induced bacteria gene expression plasticity, recapitulating
the response of yeast transcription factors with prion-like
properties in front of environmental ﬂuctuations (Alberti et al.,
2009; Malinovska et al., 2013; Newby and Lindquist, 2013).
PrionScan identiﬁes PrDs on the basis of their amino acid
compositional similitude to bona fide yeast prions, which results
in a very fast algorithm useful to scan very large databases, as
those corresponding to a complete taxon (Espinosa Angarica
et al., 2014). However, this speed comes at the cost of a lower
speciﬁcity in the predictions, when compared with competing
algorithms like PAPA (Toombs et al., 2012) and pWALTZ
(Sabate et al., 2015b). PAPA exploits the compositional bias
of PrDs to identify these domains in protein sequences using
a experimentally derived amino acid prion propensity scale
(Toombs et al., 2010), whereas pWALTZ implements a totally
diﬀerent concept, since it assumes that it is the presence and
potency of speciﬁc short amyloid-prone sequences that occur
within intrinsically disordered Q/N-rich regions that account for
prion induction (Sabate et al., 2015b).
Here, we combined PAPA and pWALTZ algorithms to get
highly speciﬁc PrDs predictions in the proteome of Clostridium
botulinum (C. botulinum). This bacterium is widely spread in the
environment, with reservoirs both in soil and water sediments
and is a well-known pathogen that aﬀects animals and humans
worldwide (Espelund and Klaveness, 2014). This approach led
us to the identiﬁcation of 54 putative prion proteins. Among
them, it outstands the transcription termination factor Rho (Rho)
(Richardson, 1990, 1996; Boudvillain et al., 2013). We show here
that its predicted PrD contains a highly polar, N-rich, short
sequence stretch able to form amyloid-like ﬁbrils, which might
endorse this RNA-binding protein with the ability to shift from
soluble to aggregated states in order to modulate its functionality.
MATERIALS AND METHODS
Prion Forming Domains identification in
Bacteria
The C. botulinum E1 str. ‘BoNT E Beluga’ proteome dataset
was downloaded from Uniprot (release 2015_05) and scanned
for PrDs using PAPA (Toombs et al., 2012) with the default
parameters, which includes the disorder prediction algorithm
FoldIndex (Prilusky et al., 2005). From the initial 3678 proteins
in the proteome, 63 prion-like candidates were identiﬁed. Their
putative prion forming domains were further evaluated with
pWALTZ (Sabate et al., 2015b) using the default parameters to
identify those domains containing a putative amyloid core, which
resulted in 54 ﬁnal positive predictions.
Clostridium botulinum PrD Peptide
Preparation
A peptide with the sequence NNNNSNFNNNSNNNSSFNNSN,
corresponding to the predicted amyloid core in the PrD of
C. botulinum Rho factor, was purchased from CASLOApS. Stock
solutions were prepared at 5 mM in DMSO and stored at −80◦C.
For analysis, the peptide was diluted to 25, 50, and 100μM in PBS
buﬀer.
Aggregation Assays
Aggregation of initial soluble species was monitored by following
the transition from non-aggregated to aggregated states by
measuring light scattering at 360 nm in 25, 50, and 100 μM
peptide samples at 25◦C. Light scattering changes were evaluated
for samples incubated during 4, 48, and 120 h.
Binding to Amyloid Dyes
The binding of 25 μM of Thioﬂavin-T (Th-T) to Rho peptide
was recorded using a Cary Eclipse Spectroﬂuorometer (Varian,
Palo Alto, CA, USA) with an excitation wavelength of 440 nm
and emission range from 460 to 600 nm at 25◦C in PBS buﬀer.
Spectra were recorded after 2 min of equilibration, and solutions
without peptide were used as negative controls. Excitation and
emission slit widths of 10 nm were used. For the staining assays
with Thioﬂavin-S (Th-S), Rho peptide aggregates were incubated
for 1 h in the presence of 125 μM of dye. After centrifugation
(14000 × g for 5 min), the precipitated fraction was washed
twice with PBS and placed on a microscope slide and sealed.
Images of Rho peptide ﬁbrils bound to Th-S were obtained at
40-fold magniﬁcation under UV light or using phase contrast
in Leica ﬂuorescence microscope (Leica DMRB, Heidelberg,
Germany).
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Congo red (CR) interaction with Rho peptide aggregates was
tested using a Cary100 UV/Vis spectrophotometer (Varian, Palo
Alto, CA, USA) by recording the absorbance spectra from 400 to
675 nm using a matched pair of quartz cuvettes of 1 cm optical
length placed in a thermostated cell holder at 25◦C. Final CR
and peptide concentrations were 5 μM in PBS buﬀer. In order
to detect the typical amyloid band at ∼541 nm, diﬀerential CR
spectra in the presence and absence of peptide were recorded.
Bis-ANS Binding
Binding of 4,4′-bis (1-anilinonaphthalene 8-sulphonat) (bis-
ANS) to Rho peptide was evaluated by registering bis-ANS
ﬂuorescence between 400 and 700 nm after excitation at 370 nm
on a Cary Eclipse Spectroﬂuorometer (Varian, Palo Alto, CA,
USA). Spectra were recorded at 25◦C in PBS buﬀer, ﬁnal
peptide and dye concentrations were 10 and 1 μM, respectively.
Excitation and emission slit widths of 10 nm were used.
Aggregation Kinetics and Seeding
Assays
Rho peptide aggregation was monitored by quantiﬁcation of the
changes in relative Th-T ﬂuorescence at 475 nm when exciting at
440 nm along time. In the seeding assay, a solution of 0.1% (w/w)
preformed ﬁbrils was added at the beginning of the reaction.
All experiments were carried out in PBS buﬀer under agitation
(∼750 rpm with micro-stir bars) at 25◦C with an initial soluble
peptide concentration of 100 μM.
Secondary Structure Determination
ATR FT-IR spectroscopy analysis of Rho peptide aggregates
was performed using a Bruker Tensor FT-IR Spectrometer
(Bruker Optics, Berlin, Germany) with a Golden Gate MKII
ATR accessory. Each spectrum consists of 16 independent scans,
measured at spectral resolution of 1 cm−1. Infrared spectra
between 1725 and 1575 cm−1 were ﬁtted through overlapping
Gaussian curves, and the amplitude, and area for each Gaussian
function were calculated employing the non-linear peak-ﬁtting
program (PeakFit package, Systat Software, San Jose, CA, USA).
Transmission Electron Microscopy (TEM)
For negative staining, samples of Rho peptide incubated at 25◦C
for 4, 48, and 120 h were placed onto carbon-coated copper
grids and left to stand for 5 min. The grids were washed with
distilled water and stained with 2% (w/v) uranyl acetate for
2 min. Micrographs were recorded in a JEM-1400 (JEOL, Japan)
transmission electron microscope (TEM) operated at 80-kV
accelerating voltage.
RESULTS
Identifying Prion-Like Domains on the
Pathogenic Bacteria Clostridium
botulinum
Recent bioinformatics screenings revealed multiple prion
candidates in bacteria, especially in pathogenic species (Espinosa
Angarica et al., 2013; Iglesias et al., 2015). In light of these data,
we focused here on the Gram-positive, anaerobic bacterium
C. botulinum, given its involvement in a number of pathological
processes (Swaminathan and Eswaramoorthy, 2000; Kumaran
et al., 2009; Rossetto et al., 2014). The analysis of the 3678 protein
sequences in C. botulinum proteome was initially performed with
PAPA (Toombs et al., 2012) and further reﬁned with pWALTZ
(Sabate et al., 2015b). Both PAPA and pWALTZ algorithms
were trained on top of yeast prions; however, they are based on
radically diﬀerent concepts, a suitable composition of the PrD
and the presence of an amyloid core embedded in it, respectively.
This ensures that sequences that pass the two thresholds should
have properties resembling previously veriﬁed yeast prions.
According to their respective scores, 54 proteins, corresponding
to 1.5% of the proteome, were identiﬁed as containing PrDs
in C. botulinum (Supplementary Table S1). Ontology analysis
indicates that the putative prion-like dataset is enriched in
biological processes related to the cell wall dynamics. However,
we also found proteins relevant in bacterial processes such as
invasion, virulence and nucleotide metabolism (Supplementary
Table S1).
We analyzed the role of the structural Pfam domains linked to
the detected C. botulinum PrD-containing proteins. As expected,
the biggest cluster of Pfam families is associated with cell wall
dynamics, with 19 out of the 41 annotated putative prions having
a cell wall binding repetition domain. Among the proteins in
that cluster we can ﬁnd a glycosyl transferase (C5UUW9), which
is a glycan synthesis eﬀector and a clear example of proteins
involved in cell wall rearrangement, with a structure combining
two diﬀerent functional domains, one glucoamylase domain
and two glycotransferase domains. The cell shape protein MreC
(C5UR99), is another relevant protein in that cluster, which
is thought to couple the internal bacterial cytoskeleton to the
extracellular cell wall synthesizing complexes; interestingly, it is
a protein that associates with penicillin-binding proteins and
guides the insertion of newly synthetized cell wall precursors
(Divakaruni et al., 2005; Tavares et al., 2015). Yet another protein
in this subset is Brachyurin (C5UXB1), a cell-wall associated
protein that contains two N-cadherin domains in its structure,
suggesting a role in cell–cell contact, adhesion and bioﬁlm
formation (Anantharaman and Aravind, 2010). The second most
abundant group of Pfam domain families is associated to invasion
and virulence processes. This group includes proteins associated
with encapsulation, sporulation and toxins. CotH (C5UUU1)
and the spore cortex-lytic enzyme (C5U536) are proteins
required either for spore coat formation (Zilhao et al., 1999)
or for spore germination, thus facilitating C. botulinum aerial
growth, surface attachment and pathogenesis. We also ﬁnd a
L,D-transpeptidase (C5UVDO), which cross-links peptidoglycan
in presence of antibiotic drugs that block regular eﬀectors
(Biarrotte-Sorin et al., 2006; Magnet et al., 2007) allowing the
bacteria to overcome classical β-lactams antibiotic blockage.
We highlight in this cluster the presence of the Botulinum
neurotoxin non-toxic-non-hemagglutinin component (NTNH).
The neurotoxin complex is composed of NTNH, the toxin BoNT,
hemagglutinin (HA) and associated subcomponent proteins and
RNAs (Wren, 1991). It has been proposed that NTNH confers
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protection against the harsh conditions the toxin faces in the
digestive tract (Sugawara et al., 2014). The third group contains
proteins with domains involved in nucleotide binding, such
the Transcription termination factor Rho (C5URV5) involved
in transcription regulation and the Ribonucleoside-diphosphate
reductase (C5UTH8) that is implicated in DNA replication.
Other relevant putative prion-like proteins that cannot be
clustered in the former groups but merit attention are StbA
(C5UUD6), a putative Hsp70 family chaperone which has been
seen to stabilize plasmids and control their number in Escherichia
coli (E. coli) (Bork et al., 1992; Guynet et al., 2011) and a
putative ggdef domain protein (C5UR68), with two relevant
functional domains, a tetratricopeptide domain, involved in
scaﬀold formation to mediate protein interactions and the
assembly of multiprotein complexes and a GGDEF domain
related with the synthesis of cyclic di-GMP and involved in the
regulation of processes such as bioﬁlm formation, motility and
cell diﬀerentiation.
Rho Factor Exhibits a Predicted PrD
Containing a Putative N-rich Amyloid
Core
Because many of the prion-like polypeptides identiﬁed in
eukaryotes are RNAbinding proteins (King et al., 2012; Kim et al.,
2013), we focused our attention in the transcription termination
factor Rho (Rho). Rho is required for the factor-dependent
transcription termination by an RNA polymerase in prokaryotes
and is essential for the viability of the cell (Richardson, 1996;
Cardinale et al., 2008; Washburn and Gottesman, 2011; Krishna
Leela et al., 2013). Recent studies indicate that besides being
a housekeeping gene, Rho can function as a gene regulator
and participates in the control of prophage maintenance in
bacterial genomes (Boudvillain et al., 2013; Menouni et al., 2013).
Accordingly, it plays a critical role in determining what proteins
are present in the cell, in what amounts and thus modulating the
organism’s phenotype.
PAPA predicts an 80 residues long PrD close to the Rho factor
N-terminus, which resides in a longer intrinsically disordered
region, as predicted with FoldIndex (Prilusky et al., 2005)
(Figure 1). pWALTZ predicts the presence of three overlapping
21 residues long amyloid stretches comprising residues 90–110,
92–112, and 93–113 inside the identiﬁed Rho PrD (Figure 1).
When we analyzed the location of structured, unstructured
and PrD regions in Rho factor, we found that, overall, its
topology resembles that observed in certain bona fide yeast
prions, like Ure2p (Figure 1). Globular domains in prion-like
proteins are responsible for their biological function. The Rho
factor consists of six identical subunits, each containing three
functional domains. The RNA binding site has been localized
to the N-terminal portion of the protein, the ATP binding site
is located in the central portion of the primary sequence, and
subunit interaction sites have been proposed to reside in the
C-terminal region (Geiselmann et al., 1993; Bogden et al., 1999).
The interaction of Rho with RNA is critical to all the activities of
the protein. Thus RNA binding is required to activate the RNA-
dependent ATPase activity of Rho. The predicted PrD and the
RNA binding domain are contiguous in Rho, a topology that is
also found in many eukaryotic prion-like proteins (King et al.,
2012; Espinosa Angarica et al., 2013; Malinovska et al., 2013;
Navarro et al., 2015).
The widely accepted “amyloid-stretch” hypothesis proposes
that the amyloid potential of amyloidogenic proteins resides
in short, highly amyloidogenic regions that act by nucleating
the aggregation reaction (Ventura et al., 2004; Esteras-Chopo
et al., 2005). We have recently proposed that this view also
applies for prion-like proteins, explaining why all known
prions adopt amyloid conformations in their propagative
state (Sabate et al., 2015a). In order to assess if this is
the case of Rho factor, we experimentally characterized the
predicted central amyloid core of the prion domain (cPrD)
using a synthetic peptide corresponding to sequence 92-
NNNNSNFNNNSNNNSSFNNSN-112, with a 67% N content.
Despite pWALTZ, which is specially intended to analyze
PrDs, predicts that this N-rich sequence would endorse the
surrounding PrD with signiﬁcant amyloidogenic potential, well-
contrasted aggregation predictors like AGGRESCAN (Conchillo-
Solé et al., 2007), TANGO (Fernandez-Escamilla et al., 2004)
or FoldAmyloid (Garbuzynskiy et al., 2010) fail to predict any
aggregation-prone region in this peptide and, indeed, they predict
it to be soluble.
Rho cPrD Forms β-sheet Enriched
Aggregates
As a ﬁrst step to experimentally characterize the selected cPrD
we analyzed its in vitro aggregation properties. Rho cPrD was
incubated at 25, 50, and 100 μM at 25◦C for 4, 48, and 120 h
and aggregation from its initially soluble state was evaluated
using synchronous light scattering (Figure 2). A concentration
dependent scattering signal is observed after 4 h. However, the
signal corresponding to the 25 and 50 μM solutions does not
evolve signiﬁcantly with time, whereas the scattering signal of the
100 μM peptide solution steadily increases to attain a maximum
after 120 h (Figure 2C). Accordingly, unless otherwise indicated,
all subsequent experiments were performed with the peptide at a
concentration of 100 μM.
For most amyloids, the self-assembly reaction depends on the
formation of intra-chain hydrophobic clusters (Hills and Brooks,
2007). However, Rho cPrD is a highly polar peptide, with less than
10% of its residues being hydrophobic. We explored the presence
of exposed hydrophobic clusters in the aggregates formed by Rho
cPrD at diﬀerent times by measuring their binding to bis-ANS
(Figure 3), a dye that increases its ﬂuorescence emission upon
interaction with these regions (Gohlke, 1972; de Groot et al.,
2007; Zhou et al., 2012). The bis-ANS ﬂuorescence emission
maximum blue-shifts from 530 nm, in the absence of peptide,
to 509 nm in the presence of the peptide after 4 h. This spectral
change is even more pronounced after 48 h, even if the global
intensity decreases. Bis-ANS ﬂuorescence emission attains a
maximum at 120 h, with its spectral maximum blue-shifted to
490 nm. These data clearly indicate that the two phenylalanine (F)
residues in Rho cPrD play an important role on its aggregation
reaction, leading to the formation of strong hydrophobic patches
in the ﬁnal aggregates.
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FIGURE 1 | Prion domains and amyloid cores as predicted in the sequences of Rho from Clostridium botulinum and the prion protein URE2 from
Saccharomyces cerevisiae. Identified Pfam domains, disordered regions, predicted PrDs and amyloid cores are shown in violet, green, blue, and red, respectively.
FIGURE 2 | Aggregation of Rho cPrD as a function of the concentration and the incubation time. Aggregation changes were monitored by light scattering
at different Rho cPrD concentrations 25 (doted line), 50 (dashed line), and 100 μM (solid line) incubated at 25◦C during (A) 4 h, (B) 120 h. The scattering at 4, 48,
and 120 h for the 100 μM peptide solution is shown in (C).
FIGURE 3 | Binding of bis-ANS to 100 μM Rho cPrD as a function of
the incubation time at 25◦C.
The aggregation of proteins into amyloid ﬁbrils results in the
formation of intermolecular β–sheets (Nelson et al., 2005). To get
insights into the secondary structure content of the assemblies
formed by Rho cPrD, we analyzed the amide I region of the FTIR
spectrum (1700–1600 cm−1) (Figure 4). This region corresponds
to the absorption of the carbonyl peptide bond group of the
protein main chain and is a sensitive marker of the protein
secondary structure. Examination of the secondary structure of
Rho cPrD peptide by deconvolved FTIR spectra allow us to assign
the individual secondary structure elements and their relative
contribution to the main absorbance signal at the beginning
(4 h) and ending (120 h) of the aggregation reaction (Figure 4;
Table 1). After 4 h of incubation the spectrum of Rho cPrD is
dominated by a band at 1663 cm−1, corresponding to disordered
structures, accounting for 74% of the total area. However, the
presence of an inter-molecular β–sheet component at 1624 cm−1
is already observable at this time point. At the end of the reaction
(120 h), the FTIR spectrum of Rho cPrD is dominated by a
band at 1633 cm−1 attributable to β–sheet conformations. At
this stage, the low frequency β–sheet components at 1607 and
1633 cm−1 together with the high frequency β–sheet component
at 1676 cm−1 account for 77% of the total area, with disordered
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FIGURE 4 | Conformational properties of 100 μM Rho cPrD as a
function of the incubation time at 25◦C during (A) 4 h, (B) 48 h.
Secondary structure was determined by ATR FT-IR. Red circles show the sum
of individual spectral components, blue lines represent different secondary
structure signals arising from Gaussian deconvolution.
conformations contributing only 23% of the signal. These spectral
properties are compatible with the assembly of Rho cPrD into a
highly β–sheet enriched amyloid-like structure.
Rho cPrD Self-Assembles into Amyloid
Fibrils
Weused the amyloid-speciﬁc dyes CR, Th-T and Th-S to conﬁrm
that the detected β–sheet enriched aggregates were organized into
amyloid-like suprastructures. The absorbance of CR increases
and the spectrum maximum red shifts to 505–510 nm in
the presence of peptide aggregates formed at 100 μM after
120 h of incubation at 25◦C (Figure 5A). This spectral change
corresponds to that promoted by diﬀerent amyloid proteins in
the aggregated state (Klunk et al., 1989). Moreover, the diﬀerence
spectrum between the dye in the presence and absence of
aggregated peptide allows detecting the characteristic amyloid
band at∼541 nm (Figure 5B). The binding of Rho cPrD to CR at
early time points is signiﬁcantly lower.
Thioﬂavin-T ﬂuorescence emission is enhanced in the
presence of amyloid ﬁbrils (LeVine, 1993; Sabate et al., 2013).
The same behavior is observed upon incubation of Th-T with
Rho cPrD (Figure 5C). In good agreement with light scattering
signals, Th-T binding to peptide solutions increases with
incubation time, the Th-T ﬂuorescence at the 480 nm spectral
maximum increasing 80-fold at 120 h. Furthermore, binding of
Th-S to 120 h aggregates could be visualized by ﬂuorescence
microscopy (Figure 5D). Areas rich in ﬁbrous material were
stained with Th-S to yield green–yellow ﬂuorescence against a
dark background.
The dye binding results indicate that incubated Rho cPrD
solutions contain detectable amounts of amyloid-like structure.
To conﬁrm this extent, the morphological features of the peptide
assemblies in these samples were analyzed using TEM. As shown
in Figure 6, we detect the presence of protein aggregates in
all cases. Nevertheless, in good agreement with spectroscopic
data, the size and morphology of the aggregates are signiﬁcantly
diﬀerent. The peptide incubated for 4 h forms short, poorly
ordered protoﬁbrilar assemblies. These assemblies coexist with
ﬁbrilar structures at the 48 h, whereas only mature ﬁbrils with
a typical amyloid-like morphology are observed at the 120 h.
Seeded protein aggregation is a well-established mechanism
for in vivo amyloid ﬁbril formation and underlies prion
propagation (Caughey, 2001; Wickner et al., 2001). The
nucleation step of the amyloid assembly is shortened in the
presence of preformed amyloid ﬁbrils of the same protein that
can act as nuclei for the subsequent polymerization reaction
(Jarrett and Lansbury, 1992). Speciﬁc and short aggregation-
prone regions have been shown to play a crucial role in this
process (Pastor et al., 2007; Sabate et al., 2012). To test whether
preformed Rho cPrD ﬁbrils can seed the aggregation of the
correspondent soluble peptide, we followed the aggregation
kinetics of the peptide at 100 μM in the presence and absence of
0.1% (w/w) preformed ﬁbrils. As shown in Figure 7, the presence
of ﬁbrils strongly accelerated the formation of Th-T positive
assemblies, raising the possibility that such speciﬁc amyloid-
promoting interactions could also occur in the context of the
complete Rho factor protein.
DISCUSSION
Prion-like proteins were initially thought to be restricted to
mammals, resulting in transmissible pathologies (Aguzzi and
Weissmann, 1998). Later on, the discovery of yeast prions
(Wickner, 1994; Du et al., 2008; Patel et al., 2009; Rogoza
et al., 2010) and more recently of prion-like proteins in
multicellular eukaryotes, from snail to human (Maji et al.,
2009; Heinrich and Lindquist, 2011; Majumdar et al., 2012;
Tariq et al., 2013; Cai and Chen, 2014), suggest that prion-like
mechanisms would sustain evolutionary conserved functions in
eukaryotic kingdoms. Despite no bacterial prion-like protein has
been characterized so far, computational predictions support the
existence of a signiﬁcant number of proteins with potential prion-
like properties in bacterial proteomes (Espinosa Angarica et al.,
2014; Iglesias et al., 2015). This is not surprising, since bacterial
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TABLE 1 | Assignment of secondary structure components of Rho cPrD peptide in the amide I region of the FTIR spectra.
Rho PrD 4 h Rho PrD 120 h
Band (cm−1) Area (%) Secondary structure Band (cm−1) Area (%) Secondary structure
1624 26 β-sheet 1607 15 β-sheet
1663 74 Loops/turns 1633 48 β-sheet
1661 23 Loops/turns
1676 14 β-sheet
FIGURE 5 | Binding Rho cPrD aggregates to specific amyloid dyes. (A) CR spectral changes in the presence of peptide incubated at different time
(B) Difference absorbance spectra of CR displaying the characteristic amyloid band at 541 nm. (C) Fluorescence emission spectrum of Th-T when excited at
440 nm; note the characteristic fluorescence enhancement at ∼480 nm when the dye is bound to amyloid aggregates. (D) Rho cPrD peptide aggregates stained
with Th-S and observed at 40X magnification by phase contrast and fluorescence microscopy displaying the green fluorescence characteristic of amyloid structures.
cells have been shown to support the formation of prion-like
conformations of yeast prions (Sabaté et al., 2009; Garrity et al.,
2010; Espargaró et al., 2012) and, more importantly, to propagate
them for over a hundred generations, even when the cells can no
longer make the protein that serves as the trigger for the initial
conversion (Yuan et al., 2014), which suggests that functional
prion-like mechanisms might be more ancient than previously
thought (Desantis et al., 2012).
As a trend, prion-like sequences are predicted to be less
abundant in bacteria than in eukaryotes (Espinosa Angarica
et al., 2013), but, interestingly, pathogenic species seem to have
a higher prion load than non-pathogenic ones. An exciting
possibility is that these sequences represent a bet-hedging
mechanism for pathogens, as suggested recently for yeast prions
(Newby and Lindquist, 2013). These mechanisms are used to
diversify microbial phenotypes. In ﬂuctuating environments this
allows a fraction of the population to survive in conditions
when most would perish. This mechanism would permit
certain cells to persist in strenuous environments like in the
presence of antibiotics or to escape the immunogenic response,
saving the population from extinction. Shuﬄing the states
of multiple prion-like proteins would allow rapid phenotypic
diversiﬁcation.
Here, we addressed the presence of potential prion-like
proteins in the proteome of the pathogen C. botulinum using a
stringent approach in which both a long region displaying amino
acid compositional similitude to bona fide prions (Toombs et al.,
2010, 2012) and the presence of a speciﬁc nucleating sequence
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FIGURE 6 | Transmission electron micrographs of Rho cPrD after 4, 48, and 120 h of incubation at 25◦C.
FIGURE 7 | Aggregation kinetics of Rho cPrD. The aggregation reactions
of 100 μM Rho cPrD were carried out under agitation at 25◦C. 0.1 μM of
in vitro formed fibrils (representing 0.1% of the final peptide concentration)
were used for the seeding assay. The formation of Rho cPrD amyloid fibrils
was accelerated in the presence of pre-aggregated peptide.
inside it (Sabate et al., 2015b) should be present for a protein
to be considered prion-like. This approach rendered a total of
54 candidates. Interestingly, the set of candidates is enriched in
proteins that play a structural role and are linked to essential
processes as cell wall metabolism or cellular shape maintenance.
Although a more exhaustive analysis of these proteins is
necessary, the data point to a possible relationship between the
identiﬁed proteins and bioﬁlm formation, which would confer a
protecting strategy and facilitate the attachment of the bacteria to
diﬀerent surfaces. Indeed, the bioﬁlms of a number of bacterial
species have been shown to contain proteins in an amyloid
conformation (Romero and Kolter, 2014) PrDs associated with
proteins involved in survival and virulence were also found in
C. botulinum. Sporulation and toxin production are powerful
strategies that facilitate the invasion of new environments and
bacterial survival in adverse conditions. In this context, proteins
involved in spore formation and degradation, the degradation-
protector NTNH in Botulism toxin and the cell-wall cross-linker
L,D-transpeptidase develop non-essential functions, but facilitate
the bacteria to remove toxic agents and evade the action of
antibiotics or from harsh natural environmental conditions and
toxic compounds (Biarrotte-Sorin et al., 2006; Magnet et al.,
2007).
A signiﬁcant number of the prion-like sequences predicted in
the human proteome correspond to RNA binding proteins (King
et al., 2012; Espinosa Angarica et al., 2013; Malinovska et al.,
2013), which ﬁts well with the fact that several experimentally
determined genuine prion-like proteins, including Ure2, Swi1,
Spf1, Cyc8, and Mot3 in yeast (Wickner, 1994; Du et al., 2008;
Alberti et al., 2009; Patel et al., 2009; Rogoza et al., 2010)
and Drosophila melanogaster’s GAGAfactor (Tariq et al., 2013)
act as transcriptional regulators. This is also the function of
the Rho factor in C. botulinum, for which we predict the
existence of a highly scoring putative PrD at the N-terminus,
adjacent to the RNA binding domain. It has been suggested
that, in the prion-like state, transcriptional regulators may
alter gene expression by creating diﬀusion barriers that restrict
protein movement toward speciﬁc subcellular locations, by
decreasing the eﬀective concentration of the freely available
pool of protein, or, on the contrary, by increasing the eﬀective
concentration in a certain location; this might result in
enough functional diversity to create phenotypic divergence
(Si, 2015). Interestingly enough, recent works have shown that
Rho inhibition allows prophage maintenance, as a strategy to
keep beneﬁcial prophage genes, while silencing those likely
to be deleterious (Cardinale et al., 2008; Menouni et al.,
2013). Importantly, the pathogenic trait in C. botulinum, the
botulinum neurotoxin, is mainly linked to a large plasmidome
consisting of plasmids and circular prophages (Skarin and
Segerman, 2014). Indeed, it has been recently shown that,
in E. coli, mutations promoting adaptive properties, such us
adaptation to thermal stress, converge to cluster either in
the RNA polymerase complex or the termination factor Rho
(Tenaillon et al., 2012; Rodriguez-Verdugo et al., 2014; Hug
and Gaut, 2015). When we analyzed the mutations reported to
occur speciﬁcally in Rho factor with our aggregation prediction
algorithm AGGRESCAN (Conchillo-Solé et al., 2007), when
found out that 72% of them endorse the terminator factor
with increased aggregation-propensity, thus suggesting a link
between the self-assembly of Rho and adaptation to changing
environments.
We provide here strong evidence that detected PrD in Rho
factor contains a short amyloid-like segment with the ability to
potentially nucleate the Rho factor PrD assembly; however, it
remains to be demonstrated if, in the case it occurs in vivo, the
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reaction would exhibit the reversibility required for considering
this protein a bona fide prion.
In contrast to pWALTZ, conventional aggregation prediction
algorithms do not capture the amyloidogenic potential of Rho
cPrD. Because these latter algorithms usually display good
accuracy when predicting the core of disease-linked amyloids
(Sabate et al., 2015b), this suggests that the principles underlying
their aggregation and that of Rho cPrD are somehow diﬀerent.
Indeed, the amyloid core of pathogenic proteins is usually very
hydrophobic, whereas 90% of Rho cPrD sequence is made
of N and S, and therefore polar, with only two hydrophobic
residues. On the one hand, while a certain amyloid nucleation
capacity favoring a suﬃciently high aggregation rate is absolutely
necessary, the ﬁnal amyloid aggregate in a prion-like protein
should at the same time display brittleness, a property that
facilitates propagation. On the other hand, the protein should
remain in a soluble state under physiological conditions, while
keeping a cryptic amyloid capacity that allows it to self-assemble
only in selected conditions. Both requirements imply that, in
contrast to most amyloids, in PrDs, the aggregation reaction
should not be nucleated by an extremely strong, and highly
hydrophobic, amyloid core. We have proposed that the role of
N residues in PrDs and their amyloid cores is to endorse these
sequences with a basal aggregation propensity, while allowing
them at the same time to remain soluble and disordered in
normal cellular conditions (Sabate et al., 2015a; Zambrano et al.,
2015). In contrast, the few hydrophobic residues found in these
cores, especially aromatic ones, would play a key role in the
initial amyloid oligomerization steps. This seems to be true
for Rho cPrD since its assembly into amyloid-like ﬁbrils is
accompanied by an increase in the presence of hydrophobic
clusters, as monitored by bis-ANS binding. It is very likely that, as
described for amyloid peptides from the Sup35 prion (Balbirnie
et al., 2001; Diaz-Avalos et al., 2003; van Der Wel et al., 2006;
Zheng et al., 2006), complete hydrogen bonding of its N and
S residues would also contribute to sustain the mature amyloid
structure.
Aggregation constraints the evolution of proteins and
accordingly nature have evolved diﬀerent strategies to minimize
protein aggregation in sequences and structures. Essentially,
mutations that result in an increase in aggregation propensity
tend to be purged out from the population, especially when
they occur in a disordered context, since they are exposed
to solvent, being this the reason that intrinsically disordered
protein segments are in general, very soluble (Santner et al.,
2012; Uversky, 2013, 2015; Graña-Montes et al., 2014). In this
context, the inherent amyloid potential of Rho cPrD strongly
suggests that this protein segment, and the surrounding predicted
PrD, are conserved because they serve functional purposes in
C. botulinum, in agreement with the general view that PrDs
are important for protein–protein interactions and provide the
ﬂexibility required to self-organizing macromolecular assemblies
in living cells (Malinovska et al., 2013; Iglesias et al., 2015).
CONCLUSION
Overall, despite the reversibility and the functionality of
C. botulinum Rho factor self-assembly should still be validated,
this study provides a ﬁrst proof for the existence of amyloidogenic
sequences embedded in the recurrent putative PrD identiﬁed
in transcription regulators of pathogenic bacteria, a property
that is compatible with them being biological capacitors that
might respond to environmental conditions rewiring gene
expression.
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